Edition:
India

Cascadian Therapeutics Inc (CASC.OQ)

CASC.OQ on NASDAQ Stock Exchange Global Select Market

3.87USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,018
52-wk High
$6.19
52-wk Low
$3.20

Select another date:

Thu, Nov 9 2017

BRIEF-Cascadian Therapeutics reports Q3 loss per share $0.28

* Cascadian Therapeutics reports third quarter 2017 financial results

BRIEF-Cascadian Therapeutics announces FDA orphan drug designation granted to Tucatinib for the treatment of HER2 colorectal cancer

* Cascadian Therapeutics announces FDA orphan drug designation granted to tucatinib for the treatment of HER2+ metastatic colorectal cancer Source text for Eikon: Further company coverage:

BRIEF-Cascadian Therapeutics Q2 loss per share $0.30

* Cascadian Therapeutics reports second quarter 2017 financial results

BRIEF-Cascadian Therapeutics announces positive regulatory update for Tucatinib in Europe

* Cascadian Therapeutics announces positive regulatory update for tucatinib in Europe

Select another date: